लोड हो रहा है...
ErbB-2 Signaling in Advanced Prostate Cancer Progression and Potential Therapy
Currently, prostate cancer (PCa) remains the most commonly diagnosed solid tumor and the second leading cause of cancer-related deaths in U.S. men. Most of these deaths are attributed to the development of castration-resistant (CR) PCa. ErbB-2 and ErbB family members have been demonstrated to contri...
में बचाया:
| में प्रकाशित: | Endocr Relat Cancer |
|---|---|
| मुख्य लेखकों: | , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
2019
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6628717/ https://ncbi.nlm.nih.gov/pubmed/31294537 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/ERC-19-0009 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|